1163 related articles for article (PubMed ID: 20426937)
21. [Clinical Characteristics and Prognostic Analysis of 59 Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Syndrome].
Zhou YL; Li F; Zhang RY; Chen ZW; Zhong N; Tang WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):657-662. PubMed ID: 32319412
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
[TBL] [Abstract][Full Text] [Related]
23. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
Lee JS; Kang JH; Lee GK; Park HJ
J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
[TBL] [Abstract][Full Text] [Related]
25. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
[TBL] [Abstract][Full Text] [Related]
26. Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report.
Przybylski M; Dzieciatkowski T; Zduńczyk D; Jedrzejczak WW; Luczak M
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):247-52. PubMed ID: 20383798
[TBL] [Abstract][Full Text] [Related]
27. [Five adult cases of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Abe Y; Shiratsuchi M; Nagasawa E; Ohtsuka R; Kiyasu J; Sada E; Idutsu K; Kotoh K; Nishimura J; Ohga S; Takayanagi R
Rinsho Ketsueki; 2010 Jan; 51(1):74-9. PubMed ID: 20134144
[TBL] [Abstract][Full Text] [Related]
28. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
[TBL] [Abstract][Full Text] [Related]
29. Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients.
Yao S; He L; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
Ann Med; 2023 Dec; 55(1):89-100. PubMed ID: 36533966
[TBL] [Abstract][Full Text] [Related]
30. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
[TBL] [Abstract][Full Text] [Related]
31. [The study of gene mutations in unknown refractory viral infection and primary hemophagocytic lymphohistiocytosis].
Tong CR; Liu HX; Xie JJ; Wang F; Cai P; Wang H; Zhu J; Teng W; Zhang X; Yang JF; Zhang YL; Fei XH; Zhao J; Yin YM; Wu T; Wang JB; Sun Y; Liu R; Shi XD; Lu DP
Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):280-3. PubMed ID: 21600143
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
[TBL] [Abstract][Full Text] [Related]
33. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
Li Y; Li S; Lu N; Wang W; Wang D
Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
[TBL] [Abstract][Full Text] [Related]
34. [Clinical risk factors for Epstein-Barr virus-associated hemophagocytic syndrome in children with infectious mononucleosis].
Guo X; Li Q; Zhou CY; Zhao YN
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):69-73. PubMed ID: 18353244
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
[TBL] [Abstract][Full Text] [Related]
36. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of clinical and laboratory features of 217 pediatric hemophagocytic lymphohistiocytosis].
Xiao L; Guan X; Meng Y; Su Y; Xian Y; Xiao J; Cui Y; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):628-32. PubMed ID: 25052607
[TBL] [Abstract][Full Text] [Related]
38. Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.
Qin Q; Xie Z; Shen Y; Yang S; Liu C; Huang Z; Xu J; Al J; Shen K
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):672-8. PubMed ID: 22774410
[TBL] [Abstract][Full Text] [Related]
39. [Clinical characteristics and follow-up of 12 cases with severe chronic active Epstein-Barr virus infection].
Song HM; Wu XY; Wang W; Xing Y; Li F; Qiu JJ; Xiao J; Wei M
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):682-6. PubMed ID: 20021792
[TBL] [Abstract][Full Text] [Related]
40. A clinicopathological analysis of 26 patients with infection-associated haemophagocytic lymphohistiocytosis and the importance of bone marrow phagocytosis for the early initiation of immunomodulatory treatment.
Nair V; Das S; Sharma A; Sharma S; Sharma P; Ray S; Bhattacharya S
Postgrad Med J; 2013 Apr; 89(1050):185-92. PubMed ID: 23243150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
